SCHEMBL21592289

SCHEMBL21592289

COc1cc(CN(CCCn2cnc3cncnc32)Cc2c(C)oc3cc(N4CCN(C)CC4)c(F)cc3c2=O)ccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21592293 0.92 MEN1 (0.31) —
SCHEMBL21592299 0.89 MAOA (0.31) —
SCHEMBL21591523 0.80 LTA4H (0.31) —
SCHEMBL21591510 0.78 PRKDC (0.38) —
SCHEMBL21591555 0.74 KCNA5 (0.40) —
SCHEMBL21592290 0.72 CYP1A2 (0.39) —
SCHEMBL21591558 0.70 MAPK13 (0.37) —
SCHEMBL21592248 0.69 CYP19A1 (0.46) —
SCHEMBL21592269 0.68 SMN1; SMN2 (0.36) —
SCHEMBL21592245 0.67 KCNA5 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220402898-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2022-12-22 — — US disclosed
WO-2019238786-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2019-12-19 — — WO disclosed
Send feedback